Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iMediSync is a South Korea-based digital mental health and neurotechnology company developing an integrated platform for brain and autonomic nervous system assessment. Its core offerings combine dry-electrode wireless EEG hardware, heart rate variability measurement, and cloud-based AI analytics to generate brain mapping and biomarker-based reports for mental health and cognitive assessment. The company markets products including iSyncWave and iSyncMe headsets, iSyncBrain analytics software, and iSyncHeart HRV analysis, with applications spanning depression, stress, anxiety, and cognitive impairment screening. iMediSync also positions its platform for tele-mental health, research collaborations, and future digital therapeutics such as QEEG-guided photobiomodulation and neurofeedback. The business appears to be primarily a commercial-stage medtech and digital health platform company rather than a traditional therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iMediSync.